rationale of transform: liso-cel vs soc in patients with high-risk r/r nhl
Published 2 years ago • 21 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
4:53
interim analysis of transform: liso-cel vs soc in high-risk r/r lbcl
-
3:59
3-year follow-up from the transform trial: liso-cel is superior to soc in r/r dlbcl
-
2:19
primary analysis of the transform study: liso-cel vs soc as second-line treatment for r/r lbcl
-
2:46
transform: liso-cel versus standard of care as second-line therapy for r/r lbcl
-
1:19
real-world outcomes of liso-cel therapy in r/r dlbcl
-
4:09
real-world safety and efficacy of liso-cel in r/r large b-cell lymphoma
-
1:48
transcend fl: liso-cel as 2l therapy in patients with high-risk r/r follicular lymphoma
-
4:40
pivotal safety and efficacy results for liso-cel in r/r b-nhl
-
15:07
introduction to neonatal jaundice
-
43:42
easl studio - s2 e17 - easl haemochromatosis guidelines 2022
-
5:54
day in the life - haematology - dr ellen maxwell
-
1:12
primary analysis of transcend-cll-004: liso-cel in r/r cll
-
2:18
matched-adjusted comparison of liso-cel versus axi-cel for the second-line treatment of r/r lbcl
-
2:40
primary analysis of the phase iii transform study: liso-cel in second-line lbcl
-
3:17
transcend-cll-004 study update: safety and efficacy of liso-cel in r/r cll
-
1:44
indirect comparison of brexu-cel versus soc in r/r mcl
-
2:27
lisocabtagene maraleucel for r/r mcl: transcend-nhl-001 update
-
1:51
liso-cel for r/r follicular lymphoma: transcend fl update
-
2:42
subcutaneous epcoritamab in r/r b-cell nhl
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
5:04
efficacy and safety of m-pola for r/r b-cell nhl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸